Key facts
- IndulgeRx’s last known valuation is $45.0M.
- It has raised $550K.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for IndulgeRx
- ·The full record, as it builds
Funding rounds
No funding rounds for IndulgeRx are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About IndulgeRx
Producer of nutritionally advanced foods intended to address the unique nutritional needs of people living with, being treated for and recovering from serious health conditions. The company's products are naturally nutritious and functional foods formulated to be calorie-dense, nutritionally intense and health-relevant to select cultures and consumers, enabling people and patients to improve their outcomes, accelerate healing and improve the treatment journey.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Woods Cross, UT, United States
- Founded
- 2017
- Employees
- 2
- Website
- indulgerx.com/
- Ownership
- Privately Held (backing)
IndulgeRx doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in IndulgeRx shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on IndulgeRx in its N-PORT filings yet. We sweep new filings monthly.